Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/200568COMPARTIR / EXPORTAR:
 SHARE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Boosting brain glucose metabolism to fight neurodegeneration? |
Autor: | Ceballos, María L. de CSIC ORCID; Köfalvi, A. | Palabras clave: | Alzheimer’s disease Cannabinoid CB2 receptor 18FDG-PET Hypometabolism |
Fecha de publicación: | 2017 | Editor: | Impact Journals | Citación: | Oncotarget 8(9): 14273-14274 (2017) | Resumen: | Alzheimer’s disease (AD) is the main cause of dementia in the elderly population with increasing prevalence. Despite the huge efforts invested in AD research, no therapeutic breakthrough has been witnessed yet. Likely, novel approaches and sweeping ideas will be necessary to effectively treat AD. Nevertheless, the earlier the disease is detected the more efficacious the therapy is. | Descripción: | © The Author(s). | Versión del editor: | http://dx.doi.org/10.18632/oncotarget.15131 | URI: | http://hdl.handle.net/10261/200568 | DOI: | 10.18632/oncotarget.15131 | E-ISSN: | 1949-2553 |
| Aparece en las colecciones: | (IC) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Boosting_Ceballos_Art2017.pdf | 615,17 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
Page view(s)
139
checked on 22-abr-2024
Download(s)
92
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons
